Selected article for: "partial thromboplastin time and thromboplastin time"

Author: Wang, Lizhen; Duan, Yueting; Zhang, Wenming; Liang, Juan; Xu, Jianxiang; Zhang, Yongqing; Wu, Changgang; Xu, Yangling; Li, Hua
Title: Epidemiologic and Clinical Characteristics of 26 Cases of COVID-19 Arising from Patient-to-Patient Transmission in Liaocheng, China
  • Document date: 2020_4_9
  • ID: k7v15131_9
    Snippet: Prothrombin time was higher and lower than normal in 2 (7.69%) and 1 (3.85%) patient, respectively. Two patients each had activated partial thromboplastin time above and below the normal range. d-Dimer level was above the normal range in 1 patient (3.85%). Procalcitonin in 24 patients (92.31%), hypersensitive C-reactive protein in 14 patients (53.85%), and serum amyloid A in 16 patients (61.54%) were higher than normal. The patients received the .....
    Document: Prothrombin time was higher and lower than normal in 2 (7.69%) and 1 (3.85%) patient, respectively. Two patients each had activated partial thromboplastin time above and below the normal range. d-Dimer level was above the normal range in 1 patient (3.85%). Procalcitonin in 24 patients (92.31%), hypersensitive C-reactive protein in 14 patients (53.85%), and serum amyloid A in 16 patients (61.54%) were higher than normal. The patients received the following treatments: antiviral therapy (100%), Chinese medicine (76.92%), antibiotics (50%), gastric mucosal protection (19.23%), immunotherapy (7.69%), and glucocorticoids (3.85%). Most patients (25/26) required ≥1 treatment (Table 2 ).

    Search related documents:
    Co phrase search for related documents